Sherman ME - Search Results

1

Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis.

Sherman ME, Rimm DL, Yang XR, Chatterjee N, Brinton LA, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, Kalaylioglu Z, Harigopal M, Charrette L, Falk RT, Richesson D, Anderson WF, Hewitt SM, García-Closas M. Sherman ME, et al. Int J Cancer. 2007 Sep 1;121(5):1079-85. doi: 10.1002/ijc.22812. Int J Cancer. 2007. PMID: 17487843 Free article.

2

Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.

Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, Rush BB, Demuth F, Schiffman M. Castle PE, et al. Among authors: sherman me. Cancer. 2002 Nov 15;95(10):2145-51. doi: 10.1002/cncr.10927. Cancer. 2002. PMID: 12412168 Free article.

3

Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998.

Mink PJ, Sherman ME, Devesa SS. Mink PJ, et al. Among authors: sherman me. Cancer. 2002 Dec 1;95(11):2380-9. doi: 10.1002/cncr.10935. Cancer. 2002. PMID: 12436446 Free article.

4

Stability of archived liquid-based cervical cytologic specimens.

Castle PE, Solomon D, Hildesheim A, Herrero R, Concepcion Bratti M, Sherman ME, Cecilia Rodriguez A, Alfaro M, Hutchinson ML, Terence Dunn S, Kuypers J, Schiffman M. Castle PE, et al. Among authors: sherman me. Cancer. 2003 Apr 25;99(2):89-96. doi: 10.1002/cncr.11058. Cancer. 2003. PMID: 12704688 Free article.

5

Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus.

Sherman ME, Devesa SS. Sherman ME, et al. Cancer. 2003 Jul 1;98(1):176-86. doi: 10.1002/cncr.11484. Cancer. 2003. PMID: 12833470 Free article.

6

Medication use and risk of ovarian carcinoma: a prospective study.

Lacey JV Jr, Sherman ME, Hartge P, Schatzkin A, Schairer C. Lacey JV Jr, et al. Among authors: sherman me. Int J Cancer. 2004 Jan 10;108(2):281-6. doi: 10.1002/ijc.11538. Int J Cancer. 2004. PMID: 14639616 Free article.

7

Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women.

Schairer C, Hill D, Sturgeon SR, Fears T, Pollak M, Mies C, Ziegler RG, Hoover RN, Sherman ME. Schairer C, et al. Among authors: sherman me. Int J Cancer. 2004 Feb 20;108(5):773-9. doi: 10.1002/ijc.11624. Int J Cancer. 2004. PMID: 14696106 Free article.

8

Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.

Curtis RE, Freedman DM, Sherman ME, Fraumeni JF Jr. Curtis RE, et al. Among authors: sherman me. J Natl Cancer Inst. 2004 Jan 7;96(1):70-4. doi: 10.1093/jnci/djh007. J Natl Cancer Inst. 2004. PMID: 14709741

9

Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.

Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. Wang SS, et al. Among authors: sherman me. Cancer. 2004 Mar 1;100(5):1035-44. doi: 10.1002/cncr.20064. Cancer. 2004. PMID: 14983500 Free article.

10

Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.

Sherman ME, Mink PJ, Curtis R, Cote TR, Brooks S, Hartge P, Devesa S. Sherman ME, et al. Cancer. 2004 Mar 1;100(5):1045-52. doi: 10.1002/cncr.20080. Cancer. 2004. PMID: 14983501 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

485 results

Search Page